Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 379.10M | £ 257.90M | £ 201.40M | £ 197.90M | £ 242.60M |
Total Assets | £ 2.45B | £ 2.10B | £ 1.94B | £ 1.85B | £ 1.66B |
Total Debt | £ 375.80M | £ 299.90M | £ 285.90M | £ 321.00M | £ 358.80M |
Net Debt | £ -3.30M | £ 42.00M | £ 84.50M | £ 123.10M | £ 116.20M |
Total Liabilities | £ 1.16B | £ 992.70M | £ 960.50M | £ 947.70M | £ 903.70M |
Stockholders Equity | £ 1.29B | £ 1.11B | £ 974.50M | £ 899.40M | £ 754.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |